Syncona: Achilles Announces Sale Of Technology Assets To …
2 hours ago · AstraZeneca has agreed to pay Achilles $12 million for the assets in total. Achilles plans to undertake additional measures, including a reduction in employee headcount and a decrease in the size ...
Achilles Therapeutics sells technology assets to AstraZeneca for …
1 day ago · Achilles Therapeutics (ACHL) announced that it has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to AstraZeneca (AZN). TRACERx, led by ...
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans …
2 days ago · Zinger Key Points. Achilles Therapeutics signs $12M deal with AstraZeneca for TRACERx data and tumor samples from lung cancer study. The company plans job cuts and Board reductions after ...
News Releases | Achilles
Nov 19, 2024 · Explore the latest innovations, and milestones at Achilles right here. Stay informed about our cutting-edge technologies, strategic collaborations, and success stories that define our commitment to excellence.
Achilles Therapeutics Announces Sale of Technology Assets to ...
2 days ago · Achilles is a clinical-stage biopharmaceutical company that has been developing AI-powered precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that ...
Achilles Therapeutics Sells Technology Assets to AstraZeneca for …
2 days ago · Achilles Therapeutics has sold certain technology assets to drug giant AstraZeneca for $12 million following a review of strategic alternatives by the clinical-stage biopharmaceutical company ...
Achilles Transfers Technology Assets From TRACERx NSCLC Study …
2 days ago · (RTTNews) - Achilles Therapeutics Plc. (ACHL), Tuesday announced that the company has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to ...
Achilles Therapeutics Reports Second Quarter 2024 Financial …
Aug 14, 2024 · ACHILLES THERAPEUTICS PLC : Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (in thousands, except share and per share amounts) (expressed in U.S. Dollars, unless otherwise stated) Three Months Ended : Six Months Ended : June 30, June 30, 2024 2023 2024 2023 ...
Achilles Therapeutics Teams Up with AstraZeneca to Accelerate ...
Dec 18, 2023 · Breaking News: Achilles Therapeutics Partners with AstraZeneca for Advanced Cancer Immunotherapy Development In a significant boost to the ongoing fight against cancer, Achilles Therapeutics Plc (NASDAQ: ACHL), a pioneer in personalized cancer immunotherapies, has announced a strategic transaction with AstraZeneca. This groundbreaking agreement will involve the transfer of proprietary data and ...
Job losses loom at Achilles as TIL therapy platform is cut
Sep 20, 2024 · Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping its R&D in tumour-infiltrating lymphocyte (TIL) therapies for cancer...
- Some results have been removed